The global smart pills market was valued at USD 1.71 billion in 2023 and is projected to experience significant growth at a compound annual growth rate (CAGR) of 11.3% from 2024 to 2030. Smart pills, commonly referred to as digital pills or ingestible sensors, represent a revolutionary advancement in medical technology by integrating pharmaceuticals with digital monitoring capabilities. These pills are embedded with miniature sensors that collect and transmit data regarding the body’s response to medication intake, including vital signs and adherence to prescribed treatments, to devices such as smartphones and computers. By providing real-time insights into patient health and the effectiveness of treatments, smart pills empower healthcare professionals to tailor treatment plans more accurately and to intervene swiftly when necessary.
Several key factors are contributing to the growth of the smart pill technologies market. These include favorable reimbursement policies, increasing patient demand for less invasive treatment options, advancements in endoscopic techniques, and a rising incidence of colon cancer. Furthermore, the advantages offered by smart pill technology—such as innovations in endoscopic procedures, targeted drug delivery, and simplified remote patient monitoring—are enhancing the sales of these technologies.
Gather more insights about the market drivers, restrains and growth of the Smart Pills Market
Application Segmentation Insights
In 2023, capsule endoscopy held a dominant position in the market, accounting for 54.1% of the revenue share, primarily due to its non-invasive approach to diagnosing gastrointestinal disorders. In this procedure, patients ingest a capsule approximately the size of a large vitamin pill, which is equipped with wireless cameras and sensors that facilitate detection and monitoring. This method is characterized by minimal discomfort and a painless experience, allowing for quick recovery. The benefits of smart pills—such as comprehensive health monitoring across various physiological metrics and precise diagnosis—are driving the expansion of the smart drugs market.
The drug delivery segment is expected to grow at a CAGR of 11.1% throughout the forecast period, fueled by infrastructural advancements in the healthcare industry, increasing patient awareness regarding chronic conditions, and the demand for sophisticated drug delivery systems that enable self-medication. There is also a global trend toward developing innovative and more comfortable drug delivery solutions to enhance patient experience.
Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.
